TWI418633B - 原核生物苯丙胺酸解氨酶組合物及使用該組合物之方法 - Google Patents

Info

Publication number

TWI418633B

TWI418633B TW097119178A TW97119178A TWI418633B TW I418633 B TWI418633 B TW I418633B TW 097119178 A TW097119178 A TW 097119178A TW 97119178 A TW97119178 A TW 97119178A TW I418633 B TWI418633 B TW I418633B

Authority

TW

Taiwan

Prior art keywords

pal

avpal

protein

peg

pegylated

Prior art date

2007-05-25

Links

• Espacenet
• Global Dossier
• Discuss

• 108700023158 Phenylalanine ammonia-lyases Proteins 0.000 title description 510
• 238000000034 method Methods 0.000 title description 140
• 239000000203 mixture Substances 0.000 title description 93
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 293
• 229920001223 polyethylene glycol Polymers 0.000 claims description 171
• 230000000694 effects Effects 0.000 claims description 170
• 239000002202 Polyethylene glycol Substances 0.000 claims description 163
• 230000006320 pegylation Effects 0.000 claims description 113
• 108090000790 Enzymes Proteins 0.000 claims description 99
• 102000004190 Enzymes Human genes 0.000 claims description 98
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 96
• 201000011252 Phenylketonuria Diseases 0.000 claims description 90
• 235000005911 diet Nutrition 0.000 claims description 57
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims description 56
• 238000011282 treatment Methods 0.000 claims description 54
• 230000035772 mutation Effects 0.000 claims description 45
• 230000037213 diet Effects 0.000 claims description 35
• 239000002253 acid Substances 0.000 claims description 34
• 238000006243 chemical reaction Methods 0.000 claims description 34
• KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 claims description 33
• 229940025084 amphetamine Drugs 0.000 claims description 33
• 239000003814 drug Substances 0.000 claims description 30
• 238000002360 preparation method Methods 0.000 claims description 25
• 125000000539 amino acid group Chemical group 0.000 claims description 23
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims description 20
• 239000008194 pharmaceutical composition Substances 0.000 claims description 14
• 230000003197 catalytic effect Effects 0.000 claims description 13
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 13
• 201000010099 disease Diseases 0.000 claims description 12
• 229940079593 drug Drugs 0.000 claims description 10
• 239000003937 drug carrier Substances 0.000 claims description 9
• 238000004519 manufacturing process Methods 0.000 claims description 9
• 241000078013 Trichormus variabilis Species 0.000 claims description 6
• 102220537984 Clavesin-1_S110C_mutation Human genes 0.000 claims description 3
• 108010074633 Mixed Function Oxygenases Proteins 0.000 claims description 3
• 102000008109 Mixed Function Oxygenases Human genes 0.000 claims description 3
• 102200021562 c.1117G>A Human genes 0.000 claims description 3
• 230000007812 deficiency Effects 0.000 claims description 3
• 102200000387 rs121917857 Human genes 0.000 claims description 3
• 102200057376 rs1553135971 Human genes 0.000 claims description 3
• 102220034979 rs199475615 Human genes 0.000 claims description 3
• 102200027736 rs5030841 Human genes 0.000 claims description 3
• 102200031316 rs5030849 Human genes 0.000 claims description 3
• 102200031487 rs5030853 Human genes 0.000 claims description 3
• 102200031113 rs5030856 Human genes 0.000 claims description 3
• 102200031139 rs5030860 Human genes 0.000 claims description 3
• 102200031429 rs62514931 Human genes 0.000 claims description 3
• 102200031124 rs62516101 Human genes 0.000 claims description 3
• 102200031116 rs62516103 Human genes 0.000 claims description 3
• 102220034971 rs62642095 Human genes 0.000 claims description 3
• 102200027738 rs62642926 Human genes 0.000 claims description 3
• 102200027873 rs62642929 Human genes 0.000 claims description 3
• 102200031143 rs62644465 Human genes 0.000 claims description 3
• 102200027764 rs76394784 Human genes 0.000 claims description 3
• 102200031444 rs76687508 Human genes 0.000 claims description 3
• 102200031393 rs77958223 Human genes 0.000 claims description 3
• 102200094634 rs80356692 Human genes 0.000 claims description 3
• 230000003213 activating effect Effects 0.000 claims 2
• 102200027763 rs75193786 Human genes 0.000 claims 2
• 238000007098 aminolysis reaction Methods 0.000 claims 1
• 230000002101 lytic effect Effects 0.000 claims 1
• 108090000623 proteins and genes Proteins 0.000 description 218
• 102000004169 proteins and genes Human genes 0.000 description 193
• 235000018102 proteins Nutrition 0.000 description 189
• 210000002381 plasma Anatomy 0.000 description 150
• 229940088598 enzyme Drugs 0.000 description 96
• 229960005190 phenylalanine Drugs 0.000 description 94
• 235000018417 cysteine Nutrition 0.000 description 65
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 65
• 230000002829 reductive effect Effects 0.000 description 63
• 241000699670 Mus sp. Species 0.000 description 61
• 230000001225 therapeutic effect Effects 0.000 description 53
• 108090000765 processed proteins & peptides Proteins 0.000 description 52
• 230000001580 bacterial effect Effects 0.000 description 50
• NPOCDVAOUKODSQ-ZDUSSCGKSA-N (2s)-2-amino-6-[6-(2-methoxyethoxy)hexanoylamino]hexanoic acid Chemical class COCCOCCCCCC(=O)NCCCC[C@H](N)C(O)=O NPOCDVAOUKODSQ-ZDUSSCGKSA-N 0.000 description 44
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 44
• 238000012360 testing method Methods 0.000 description 44
• 230000015572 biosynthetic process Effects 0.000 description 41
• 230000005847 immunogenicity Effects 0.000 description 41
• 102000004196 processed proteins & peptides Human genes 0.000 description 41
• 102000040430 polynucleotide Human genes 0.000 description 40
• 108091033319 polynucleotide Proteins 0.000 description 40
• 239000002157 polynucleotide Substances 0.000 description 40
• 210000004369 blood Anatomy 0.000 description 39
• 239000008280 blood Substances 0.000 description 39
• 210000004027 cell Anatomy 0.000 description 39
• 108020004414 DNA Proteins 0.000 description 38
• 235000001014 amino acid Nutrition 0.000 description 37
• 229920001184 polypeptide Polymers 0.000 description 37
• 229940024606 amino acid Drugs 0.000 description 34
• 229960001153 serine Drugs 0.000 description 34
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 33
• 125000003729 nucleotide group Chemical group 0.000 description 32
• 239000000243 solution Substances 0.000 description 32
• 239000012634 fragment Substances 0.000 description 31
• 239000002773 nucleotide Substances 0.000 description 31
• 210000002966 serum Anatomy 0.000 description 31
• 150000001413 amino acids Chemical class 0.000 description 29
• 238000000338 in vitro Methods 0.000 description 29
• 239000000872 buffer Substances 0.000 description 28
• 238000005755 formation reaction Methods 0.000 description 28
• 241001465754 Metazoa Species 0.000 description 27
• -1 casein amino acid Chemical class 0.000 description 26
• 238000009472 formulation Methods 0.000 description 26
• 238000001727 in vivo Methods 0.000 description 26
• 239000000523 sample Substances 0.000 description 26
• 238000002560 therapeutic procedure Methods 0.000 description 26
• 238000003556 assay Methods 0.000 description 25
• 238000006467 substitution reaction Methods 0.000 description 25
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 24
• 229920000642 polymer Polymers 0.000 description 24
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 23
• 230000000378 dietary effect Effects 0.000 description 22
• 241000894006 Bacteria Species 0.000 description 21
• 108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 21
• 230000001965 increasing effect Effects 0.000 description 20
• 150000007523 nucleic acids Chemical group 0.000 description 20
• 230000009467 reduction Effects 0.000 description 20
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 19
• 102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 19
• WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 18
• 238000004458 analytical method Methods 0.000 description 18
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 18
• 239000003981 vehicle Substances 0.000 description 18
• 241000192542 Anabaena Species 0.000 description 17
• 241000195493 Cryptophyta Species 0.000 description 17
• 102000035195 Peptidases Human genes 0.000 description 17
• 108091005804 Peptidases Proteins 0.000 description 17
• 238000004422 calculation algorithm Methods 0.000 description 17
• 230000007423 decrease Effects 0.000 description 17
• 230000001976 improved effect Effects 0.000 description 17
• 239000000047 product Substances 0.000 description 17
• 230000002797 proteolythic effect Effects 0.000 description 17
• 239000000126 substance Substances 0.000 description 17
• 229960004441 tyrosine Drugs 0.000 description 17
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 16
• 239000004365 Protease Substances 0.000 description 16
• 230000002776 aggregation Effects 0.000 description 16
• 238000004220 aggregation Methods 0.000 description 16
• 238000009396 hybridization Methods 0.000 description 16
• 239000007924 injection Substances 0.000 description 16
• 238000002347 injection Methods 0.000 description 16
• 102000039446 nucleic acids Human genes 0.000 description 16
• 108020004707 nucleic acids Proteins 0.000 description 16
• 238000012216 screening Methods 0.000 description 16
• 102000015781 Dietary Proteins Human genes 0.000 description 15
• 108010010256 Dietary Proteins Proteins 0.000 description 15
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 15
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
• 230000000295 complement effect Effects 0.000 description 15
• 235000021245 dietary protein Nutrition 0.000 description 15
• 230000002163 immunogen Effects 0.000 description 15
• 230000004048 modification Effects 0.000 description 15
• 238000012986 modification Methods 0.000 description 15
• 230000002441 reversible effect Effects 0.000 description 15
• 230000035945 sensitivity Effects 0.000 description 15
• 150000001412 amines Chemical class 0.000 description 14
• 230000009286 beneficial effect Effects 0.000 description 14
• 230000002255 enzymatic effect Effects 0.000 description 14
• 238000011534 incubation Methods 0.000 description 14
• 230000004845 protein aggregation Effects 0.000 description 14
• 239000013589 supplement Substances 0.000 description 14
• 241000187747 Streptomyces Species 0.000 description 13
• 150000001875 compounds Chemical class 0.000 description 13
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 13
• 108020004705 Codon Proteins 0.000 description 12
• 230000037396 body weight Effects 0.000 description 12
• 238000001212 derivatisation Methods 0.000 description 12
• 150000003839 salts Chemical class 0.000 description 12
• 241000894007 species Species 0.000 description 12
• 238000007920 subcutaneous administration Methods 0.000 description 12
• 239000013598 vector Substances 0.000 description 12
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
• 238000001818 capillary gel electrophoresis Methods 0.000 description 11
• 239000002299 complementary DNA Substances 0.000 description 11
• 235000020805 dietary restrictions Nutrition 0.000 description 11
• 239000002158 endotoxin Substances 0.000 description 11
• 102220102437 rs878855252 Human genes 0.000 description 11
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 10
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 10
• 208000014252 Mild phenylketonuria Diseases 0.000 description 10
• 241000699666 Mus <mouse, genus> Species 0.000 description 10
• 108091028043 Nucleic acid sequence Proteins 0.000 description 10
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 10
• 238000013461 design Methods 0.000 description 10
• VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 10
• 238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 description 10
• 239000002904 solvent Substances 0.000 description 10
• WBYWAXJHAXSJNI-VOTSOKGWSA-N trans-cinnamic acid Chemical compound OC(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-N 0.000 description 10
• 230000003442 weekly effect Effects 0.000 description 10
• 108091033380 Coding strand Proteins 0.000 description 9
• 241000589776 Pseudomonas putida Species 0.000 description 9
• 125000003275 alpha amino acid group Chemical group 0.000 description 9
• 238000005119 centrifugation Methods 0.000 description 9
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 9
• 230000004807 localization Effects 0.000 description 9
• 235000018977 lysine Nutrition 0.000 description 9
• 239000000546 pharmaceutical excipient Substances 0.000 description 9
• 210000002706 plastid Anatomy 0.000 description 9
• 238000003786 synthesis reaction Methods 0.000 description 9
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 8
• 239000004472 Lysine Substances 0.000 description 8
• 206010028980 Neoplasm Diseases 0.000 description 8
• 238000007792 addition Methods 0.000 description 8
• 239000011324 bead Substances 0.000 description 8
• 201000011510 cancer Diseases 0.000 description 8
• 230000008859 change Effects 0.000 description 8
• 238000012512 characterization method Methods 0.000 description 8
• 238000007385 chemical modification Methods 0.000 description 8
• 238000011156 evaluation Methods 0.000 description 8
• 230000006870 function Effects 0.000 description 8
• 230000002366 lipolytic effect Effects 0.000 description 8
• 239000006166 lysate Substances 0.000 description 8
• 229960003646 lysine Drugs 0.000 description 8
• 229920002521 macromolecule Polymers 0.000 description 8
• 108020004999 messenger RNA Proteins 0.000 description 8
• 238000002703 mutagenesis Methods 0.000 description 8
• 231100000350 mutagenesis Toxicity 0.000 description 8
• 239000003921 oil Substances 0.000 description 8
• 238000005457 optimization Methods 0.000 description 8
• 235000021075 protein intake Nutrition 0.000 description 8
• 239000003656 tris buffered saline Substances 0.000 description 8
• 239000012588 trypsin Substances 0.000 description 8
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 7
• 241000222122 Candida albicans Species 0.000 description 7
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 7
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 7
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 7
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 7
• 108090000631 Trypsin Proteins 0.000 description 7
• 102000004142 Trypsin Human genes 0.000 description 7
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 7
• 238000002835 absorbance Methods 0.000 description 7
• 229940095731 candida albicans Drugs 0.000 description 7
• 238000004132 cross linking Methods 0.000 description 7
• 239000002552 dosage form Substances 0.000 description 7
• 235000013305 food Nutrition 0.000 description 7
• 235000011187 glycerol Nutrition 0.000 description 7
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 7
• 239000000463 material Substances 0.000 description 7
• 239000000178 monomer Substances 0.000 description 7
• 229910052698 phosphorus Inorganic materials 0.000 description 7
• 230000035935 pregnancy Effects 0.000 description 7
• 238000002741 site-directed mutagenesis Methods 0.000 description 7
• 239000011780 sodium chloride Substances 0.000 description 7
• 239000000758 substrate Substances 0.000 description 7
• 208000024891 symptom Diseases 0.000 description 7
• 229920003169 water-soluble polymer Polymers 0.000 description 7
• 238000001262 western blot Methods 0.000 description 7
• WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 6
• 244000000626 Daucus carota Species 0.000 description 6
• 235000002767 Daucus carota Nutrition 0.000 description 6
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
• 238000002965 ELISA Methods 0.000 description 6
• 241000196324 Embryophyta Species 0.000 description 6
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 6
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 6
• 101710189920 Peptidyl-alpha-hydroxyglycine alpha-amidating lyase Proteins 0.000 description 6
• 239000000205 acacia gum Substances 0.000 description 6
• 238000010171 animal model Methods 0.000 description 6
• 230000008901 benefit Effects 0.000 description 6
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
• 210000004899 c-terminal region Anatomy 0.000 description 6
• 229930016911 cinnamic acid Natural products 0.000 description 6
• 235000013985 cinnamic acid Nutrition 0.000 description 6
• 235000018823 dietary intake Nutrition 0.000 description 6
• 239000003085 diluting agent Substances 0.000 description 6
• 239000003925 fat Substances 0.000 description 6
• 239000003112 inhibitor Substances 0.000 description 6
• 238000005259 measurement Methods 0.000 description 6
• 239000002609 medium Substances 0.000 description 6
• WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 6
• 239000002504 physiological saline solution Substances 0.000 description 6
• 230000008569 process Effects 0.000 description 6
• 238000012545 processing Methods 0.000 description 6
• 229940116540 protein supplement Drugs 0.000 description 6
• 235000005974 protein supplement Nutrition 0.000 description 6
• 239000007787 solid Substances 0.000 description 6
• 229910052717 sulfur Inorganic materials 0.000 description 6
• 239000000725 suspension Substances 0.000 description 6
• 229960004295 valine Drugs 0.000 description 6
• 238000005406 washing Methods 0.000 description 6
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 5
• 241000192700 Cyanobacteria Species 0.000 description 5
• 102000053602 DNA Human genes 0.000 description 5
• 241000588724 Escherichia coli Species 0.000 description 5
• 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 5
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 5
• 241000124008 Mammalia Species 0.000 description 5
• HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 5
• 241000208422 Rhododendron Species 0.000 description 5
• 241001414751 Rhodospora Species 0.000 description 5
• 229960003767 alanine Drugs 0.000 description 5
• 229910021529 ammonia Inorganic materials 0.000 description 5
• 230000000890 antigenic effect Effects 0.000 description 5
• 238000013459 approach Methods 0.000 description 5
• 229960005261 aspartic acid Drugs 0.000 description 5
• 239000004202 carbamide Substances 0.000 description 5
• 239000003795 chemical substances by application Substances 0.000 description 5
• 239000005516 coenzyme A Substances 0.000 description 5
• 229940093530 coenzyme a Drugs 0.000 description 5
• 239000013078 crystal Substances 0.000 description 5
• 230000001186 cumulative effect Effects 0.000 description 5
• 238000012217 deletion Methods 0.000 description 5
• 230000037430 deletion Effects 0.000 description 5
• 238000010790 dilution Methods 0.000 description 5
• 239000012895 dilution Substances 0.000 description 5
• 238000001914 filtration Methods 0.000 description 5
• 239000012467 final product Substances 0.000 description 5
• 235000013350 formula milk Nutrition 0.000 description 5
• 239000000499 gel Substances 0.000 description 5
• 239000008103 glucose Substances 0.000 description 5
• 239000002054 inoculum Substances 0.000 description 5
• 238000002372 labelling Methods 0.000 description 5
• 229960003136 leucine Drugs 0.000 description 5
• 230000007774 longterm Effects 0.000 description 5
• 235000012054 meals Nutrition 0.000 description 5
• 230000007246 mechanism Effects 0.000 description 5
• 230000001575 pathological effect Effects 0.000 description 5
• 229920000136 polysorbate Polymers 0.000 description 5
• 230000004044 response Effects 0.000 description 5
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
• 239000006228 supernatant Substances 0.000 description 5
• XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 5
• 238000013518 transcription Methods 0.000 description 5
• 230000035897 transcription Effects 0.000 description 5
• 239000004474 valine Substances 0.000 description 5
• NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 4
• 241001552669 Adonis annua Species 0.000 description 4
• 239000004475 Arginine Substances 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 4
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 4
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
• 102000004317 Lyases Human genes 0.000 description 4
• 108090000856 Lyases Proteins 0.000 description 4
• 244000141359 Malus pumila Species 0.000 description 4
• 235000011430 Malus pumila Nutrition 0.000 description 4
• 240000003183 Manihot esculenta Species 0.000 description 4
• 229910019142 PO4 Inorganic materials 0.000 description 4
• 241001662443 Phemeranthus parviflorus Species 0.000 description 4
• 241000223252 Rhodotorula Species 0.000 description 4
• 239000000654 additive Substances 0.000 description 4
• 230000002411 adverse Effects 0.000 description 4
• 235000004279 alanine Nutrition 0.000 description 4
• 125000003277 amino group Chemical group 0.000 description 4
• 239000000427 antigen Substances 0.000 description 4
• 102000036639 antigens Human genes 0.000 description 4
• 108091007433 antigens Proteins 0.000 description 4
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
• 235000009697 arginine Nutrition 0.000 description 4
• 229960003121 arginine Drugs 0.000 description 4
• 235000003704 aspartic acid Nutrition 0.000 description 4
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
• 230000008033 biological extinction Effects 0.000 description 4
• 210000004556 brain Anatomy 0.000 description 4
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
• 210000004900 c-terminal fragment Anatomy 0.000 description 4
• 239000002775 capsule Substances 0.000 description 4
• 238000011210 chromatographic step Methods 0.000 description 4
• 239000012539 chromatography resin Substances 0.000 description 4
• 238000002648 combination therapy Methods 0.000 description 4
• 238000009295 crossflow filtration Methods 0.000 description 4
• 238000003745 diagnosis Methods 0.000 description 4
• 231100000673 dose–response relationship Toxicity 0.000 description 4
• 239000003995 emulsifying agent Substances 0.000 description 4
• 238000012407 engineering method Methods 0.000 description 4
• 238000002474 experimental method Methods 0.000 description 4
• 238000001502 gel electrophoresis Methods 0.000 description 4
• 229960002989 glutamic acid Drugs 0.000 description 4
• NTYJJOPFIAHURM-UHFFFAOYSA-N histamine Natural products NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
• 238000001114 immunoprecipitation Methods 0.000 description 4
• 230000003993 interaction Effects 0.000 description 4
• 238000001990 intravenous administration Methods 0.000 description 4
• 229960000310 isoleucine Drugs 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
• 238000004949 mass spectrometry Methods 0.000 description 4
• 239000012528 membrane Substances 0.000 description 4
• 238000012544 monitoring process Methods 0.000 description 4
• 230000007935 neutral effect Effects 0.000 description 4
• 231100000252 nontoxic Toxicity 0.000 description 4
• 230000003000 nontoxic effect Effects 0.000 description 4
• 235000021317 phosphate Nutrition 0.000 description 4
• 239000002953 phosphate buffered saline Substances 0.000 description 4
• 238000002731 protein assay Methods 0.000 description 4
• 238000000746 purification Methods 0.000 description 4
• 239000011541 reaction mixture Substances 0.000 description 4
• QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
• 238000003860 storage Methods 0.000 description 4
• 239000007929 subcutaneous injection Substances 0.000 description 4
• 238000010254 subcutaneous injection Methods 0.000 description 4
• PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 3
• UBAVPHLFRVPRCI-CRBCFSCISA-N 2-[[(e)-2-carboxyethenyl]amino]-n-methoxy-2-oxoethanimine oxide Chemical compound CO\[N+]([O-])=C\C(=O)N\C=C\C(O)=O UBAVPHLFRVPRCI-CRBCFSCISA-N 0.000 description 3
• 241000251468 Actinopterygii Species 0.000 description 3
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
• WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 3
• 241000283707 Capra Species 0.000 description 3
• 240000001829 Catharanthus roseus Species 0.000 description 3
• 108090000317 Chymotrypsin Proteins 0.000 description 3
• 235000010523 Cicer arietinum Nutrition 0.000 description 3
• 244000045195 Cicer arietinum Species 0.000 description 3
• 235000005979 Citrus limon Nutrition 0.000 description 3
• 244000131522 Citrus pyriformis Species 0.000 description 3
• 229920002307 Dextran Polymers 0.000 description 3
• 241000233866 Fungi Species 0.000 description 3
• 206010064571 Gene mutation Diseases 0.000 description 3
• 235000010469 Glycine max Nutrition 0.000 description 3
• 244000068988 Glycine max Species 0.000 description 3
• 244000020551 Helianthus annuus Species 0.000 description 3
• 235000003222 Helianthus annuus Nutrition 0.000 description 3
• 206010020565 Hyperaemia Diseases 0.000 description 3
• 244000017020 Ipomoea batatas Species 0.000 description 3
• 235000002678 Ipomoea batatas Nutrition 0.000 description 3
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• 240000008415 Lactuca sativa Species 0.000 description 3
• 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
• 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 3
• 208000000481 Maternal phenylketonuria Diseases 0.000 description 3
• 102000018697 Membrane Proteins Human genes 0.000 description 3
• 108010052285 Membrane Proteins Proteins 0.000 description 3
• GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 3
• NSTPXGARCQOSAU-VIFPVBQESA-N N-formyl-L-phenylalanine Chemical compound O=CN[C@H](C(=O)O)CC1=CC=CC=C1 NSTPXGARCQOSAU-VIFPVBQESA-N 0.000 description 3
• 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
• 244000061176 Nicotiana tabacum Species 0.000 description 3
• 241000192656 Nostoc Species 0.000 description 3
• 206010030113 Oedema Diseases 0.000 description 3
• 240000007594 Oryza sativa Species 0.000 description 3
• 235000007164 Oryza sativa Nutrition 0.000 description 3
• 108091006006 PEGylated Proteins Proteins 0.000 description 3
• 244000025272 Persea americana Species 0.000 description 3
• 235000008673 Persea americana Nutrition 0.000 description 3
• 240000009164 Petroselinum crispum Species 0.000 description 3
• 244000046052 Phaseolus vulgaris Species 0.000 description 3
• 240000004713 Pisum sativum Species 0.000 description 3
• 108010030975 Polyketide Synthases Proteins 0.000 description 3
• 229920001213 Polysorbate 20 Polymers 0.000 description 3
• 241000218976 Populus trichocarpa Species 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 244000235659 Rubus idaeus Species 0.000 description 3
• 235000009122 Rubus idaeus Nutrition 0.000 description 3
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
• 240000003768 Solanum lycopersicum Species 0.000 description 3
• 235000002595 Solanum tuberosum Nutrition 0.000 description 3
• 244000061456 Solanum tuberosum Species 0.000 description 3
• 241001587868 Streptomyces marinus Species 0.000 description 3
• 239000007983 Tris buffer Substances 0.000 description 3
• 244000098338 Triticum aestivum Species 0.000 description 3
• 241000700605 Viruses Species 0.000 description 3
• 240000006365 Vitis vinifera Species 0.000 description 3
• 235000014787 Vitis vinifera Nutrition 0.000 description 3
• 240000008042 Zea mays Species 0.000 description 3
• 239000013543 active substance Substances 0.000 description 3
• 239000002671 adjuvant Substances 0.000 description 3
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 3
• 230000003321 amplification Effects 0.000 description 3
• AFYNADDZULBEJA-UHFFFAOYSA-N bicinchoninic acid Chemical compound C1=CC=CC2=NC(C=3C=C(C4=CC=CC=C4N=3)C(=O)O)=CC(C(O)=O)=C21 AFYNADDZULBEJA-UHFFFAOYSA-N 0.000 description 3
• 238000003766 bioinformatics method Methods 0.000 description 3
• 239000007853 buffer solution Substances 0.000 description 3
• 235000012970 cakes Nutrition 0.000 description 3
• 238000006555 catalytic reaction Methods 0.000 description 3
• 150000001768 cations Chemical class 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 239000007795 chemical reaction product Substances 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• 229960002376 chymotrypsin Drugs 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 238000009510 drug design Methods 0.000 description 3
• 230000009977 dual effect Effects 0.000 description 3
• 239000000839 emulsion Substances 0.000 description 3
• 150000002148 esters Chemical class 0.000 description 3
• 238000013401 experimental design Methods 0.000 description 3
• 239000013604 expression vector Substances 0.000 description 3
• 108020001507 fusion proteins Proteins 0.000 description 3
• 102000037865 fusion proteins Human genes 0.000 description 3
• 235000013922 glutamic acid Nutrition 0.000 description 3
• 239000004220 glutamic acid Substances 0.000 description 3
• 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 230000003862 health status Effects 0.000 description 3
• 230000002209 hydrophobic effect Effects 0.000 description 3
• 238000004191 hydrophobic interaction chromatography Methods 0.000 description 3
• 230000028993 immune response Effects 0.000 description 3
• 230000001939 inductive effect Effects 0.000 description 3
• 229910052500 inorganic mineral Inorganic materials 0.000 description 3
• 238000007918 intramuscular administration Methods 0.000 description 3
• PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 3
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 229920001427 mPEG Polymers 0.000 description 3
• 230000014759 maintenance of location Effects 0.000 description 3
• 230000008774 maternal effect Effects 0.000 description 3
• 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 3
• 229960004452 methionine Drugs 0.000 description 3
• 208000026770 mild hyperphenylalaninemia Diseases 0.000 description 3
• 239000011707 mineral Substances 0.000 description 3
• 238000002156 mixing Methods 0.000 description 3
• 229930014626 natural product Natural products 0.000 description 3
• 238000003199 nucleic acid amplification method Methods 0.000 description 3
• 101150077062 pal gene Proteins 0.000 description 3
• 239000008188 pellet Substances 0.000 description 3
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
• 239000003755 preservative agent Substances 0.000 description 3
• 230000000750 progressive effect Effects 0.000 description 3
• 239000012460 protein solution Substances 0.000 description 3
• 230000006798 recombination Effects 0.000 description 3
• 238000005215 recombination Methods 0.000 description 3
• 239000004627 regenerated cellulose Substances 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 3
• 238000007423 screening assay Methods 0.000 description 3
• 230000001502 supplementing effect Effects 0.000 description 3
• 239000000375 suspending agent Substances 0.000 description 3
• 239000012085 test solution Substances 0.000 description 3
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
• 238000011179 visual inspection Methods 0.000 description 3
• 239000000080 wetting agent Substances 0.000 description 3
• AOFUBOWZWQFQJU-SNOJBQEQSA-N (2r,3s,4s,5r)-2,5-bis(hydroxymethyl)oxolane-2,3,4-triol;(2s,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O AOFUBOWZWQFQJU-SNOJBQEQSA-N 0.000 description 2
• SJHPCNCNNSSLPL-CSKARUKUSA-N (4e)-4-(ethoxymethylidene)-2-phenyl-1,3-oxazol-5-one Chemical compound O1C(=O)C(=C/OCC)\N=C1C1=CC=CC=C1 SJHPCNCNNSSLPL-CSKARUKUSA-N 0.000 description 2
• VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 2
• XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 2
• NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
• 229920001817 Agar Polymers 0.000 description 2
• RTZCUEHYUQZIDE-WHFBIAKZSA-N Ala-Ser-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RTZCUEHYUQZIDE-WHFBIAKZSA-N 0.000 description 2
• 241000134914 Amanita muscaria Species 0.000 description 2
• PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
• 241000219195 Arabidopsis thaliana Species 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 108010011485 Aspartame Proteins 0.000 description 2
• 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
• 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
• 235000014469 Bacillus subtilis Nutrition 0.000 description 2
• 235000004270 Bambusa oldhamii Nutrition 0.000 description 2
• 235000017647 Brassica oleracea var italica Nutrition 0.000 description 2
• 244000308180 Brassica oleracea var. italica Species 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• 235000002187 Coffea robusta Nutrition 0.000 description 2
• 208000002330 Congenital Heart Defects Diseases 0.000 description 2
• 206010010356 Congenital anomaly Diseases 0.000 description 2
• 229920000858 Cyclodextrin Polymers 0.000 description 2
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
• 240000001879 Digitalis lutea Species 0.000 description 2
• 108700036505 EC 4.3.1.5 Proteins 0.000 description 2
• 238000012286 ELISA Assay Methods 0.000 description 2
• ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
• 208000017604 Hodgkin disease Diseases 0.000 description 2
• QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
• XVOYSCVBGLVSOL-REOHCLBHSA-N L-cysteic acid Chemical group OC(=O)[C@@H](N)CS(O)(=O)=O XVOYSCVBGLVSOL-REOHCLBHSA-N 0.000 description 2
• 229930182816 L-glutamine Natural products 0.000 description 2
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
• 235000003228 Lactuca sativa Nutrition 0.000 description 2
• 229930195725 Mannitol Natural products 0.000 description 2
• 240000004658 Medicago sativa Species 0.000 description 2
• 208000036626 Mental retardation Diseases 0.000 description 2
• 102000008300 Mutant Proteins Human genes 0.000 description 2
• 108010021466 Mutant Proteins Proteins 0.000 description 2
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
• 108091034117 Oligonucleotide Proteins 0.000 description 2
• 241000233855 Orchidaceae Species 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 238000012408 PCR amplification Methods 0.000 description 2
• 108091093037 Peptide nucleic acid Proteins 0.000 description 2
• 235000002770 Petroselinum crispum Nutrition 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 235000008566 Pinus taeda Nutrition 0.000 description 2
• 241000218679 Pinus taeda Species 0.000 description 2
• 235000010582 Pisum sativum Nutrition 0.000 description 2
• 239000004721 Polyphenylene oxide Substances 0.000 description 2
• 235000011263 Populus tremuloides Nutrition 0.000 description 2
• 240000004923 Populus tremuloides Species 0.000 description 2
• 244000007021 Prunus avium Species 0.000 description 2
• 235000010401 Prunus avium Nutrition 0.000 description 2
• 235000016977 Quercus suber Nutrition 0.000 description 2
• 240000008289 Quercus suber Species 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
• 102000018120 Recombinases Human genes 0.000 description 2
• 108010091086 Recombinases Proteins 0.000 description 2
• 241001361634 Rhizoctonia Species 0.000 description 2
• 241000223254 Rhodotorula mucilaginosa Species 0.000 description 2
• 241000221523 Rhodotorula toruloides Species 0.000 description 2
• 235000011034 Rubus glaucus Nutrition 0.000 description 2
• 241001466077 Salina Species 0.000 description 2
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
• 241000792444 Stellaria longipes Species 0.000 description 2
• 240000002726 Stylosanthes sundaica Species 0.000 description 2
• 239000006180 TBST buffer Substances 0.000 description 2
• 244000269722 Thea sinensis Species 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• 241000219870 Trifolium subterraneum Species 0.000 description 2
• 235000021307 Triticum Nutrition 0.000 description 2
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
• 235000009754 Vitis X bourquina Nutrition 0.000 description 2
• 235000012333 Vitis X labruscana Nutrition 0.000 description 2
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
• 210000001015 abdomen Anatomy 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• 230000021736 acetylation Effects 0.000 description 2
• 238000006640 acetylation reaction Methods 0.000 description 2
• 239000004480 active ingredient Substances 0.000 description 2
• 239000008272 agar Substances 0.000 description 2
• 238000013019 agitation Methods 0.000 description 2
• 108010086434 alanyl-seryl-glycine Proteins 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 125000003118 aryl group Chemical group 0.000 description 2
• 235000010357 aspartame Nutrition 0.000 description 2
• 239000000605 aspartame Substances 0.000 description 2
• IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
• 229960003438 aspartame Drugs 0.000 description 2
• 229940009098 aspartate Drugs 0.000 description 2
• 238000003149 assay kit Methods 0.000 description 2
• 125000004429 atom Chemical group 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
• 235000013361 beverage Nutrition 0.000 description 2
• 230000000975 bioactive effect Effects 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 230000000903 blocking effect Effects 0.000 description 2
• 229940041514 candida albicans extract Drugs 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 150000007942 carboxylates Chemical group 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 239000005018 casein Substances 0.000 description 2
• 235000021240 caseins Nutrition 0.000 description 2
• 125000002091 cationic group Chemical group 0.000 description 2
• 239000006143 cell culture medium Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 238000011097 chromatography purification Methods 0.000 description 2
• APEJMQOBVMLION-UHFFFAOYSA-N cinnamamide Chemical compound NC(=O)C=CC1=CC=CC=C1 APEJMQOBVMLION-UHFFFAOYSA-N 0.000 description 2
• 229940114081 cinnamate Drugs 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 230000001149 cognitive effect Effects 0.000 description 2
• 230000002860 competitive effect Effects 0.000 description 2
• 239000012141 concentrate Substances 0.000 description 2
• 235000008504 concentrate Nutrition 0.000 description 2
• 208000028831 congenital heart disease Diseases 0.000 description 2
• 239000000356 contaminant Substances 0.000 description 2
• 238000002425 crystallisation Methods 0.000 description 2
• 230000008025 crystallization Effects 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 230000002939 deleterious effect Effects 0.000 description 2
• 238000011118 depth filtration Methods 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• 238000002405 diagnostic procedure Methods 0.000 description 2
• 229910000071 diazene Inorganic materials 0.000 description 2
• 235000021196 dietary intervention Nutrition 0.000 description 2
• 235000015872 dietary supplement Nutrition 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 238000007865 diluting Methods 0.000 description 2
• 238000010494 dissociation reaction Methods 0.000 description 2
• 230000005593 dissociations Effects 0.000 description 2
• 238000004090 dissolution Methods 0.000 description 2
• VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 230000001747 exhibiting effect Effects 0.000 description 2
• 230000002349 favourable effect Effects 0.000 description 2
• 210000003754 fetus Anatomy 0.000 description 2
• 239000000706 filtrate Substances 0.000 description 2
• 230000037406 food intake Effects 0.000 description 2
• 235000003599 food sweetener Nutrition 0.000 description 2
• 239000007903 gelatin capsule Substances 0.000 description 2
• 102000054767 gene variant Human genes 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 235000001727 glucose Nutrition 0.000 description 2
• 230000013595 glycosylation Effects 0.000 description 2
• 238000006206 glycosylation reaction Methods 0.000 description 2
• 239000001963 growth medium Substances 0.000 description 2
• BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 2
• 229960003132 halothane Drugs 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 239000004009 herbicide Substances 0.000 description 2
• 238000012203 high throughput assay Methods 0.000 description 2
• 229960001340 histamine Drugs 0.000 description 2
• 235000020256 human milk Nutrition 0.000 description 2
• 210000004251 human milk Anatomy 0.000 description 2
• 125000002883 imidazolyl group Chemical group 0.000 description 2
• 230000009851 immunogenic response Effects 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000037431 insertion Effects 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 239000007928 intraperitoneal injection Substances 0.000 description 2
• 238000005342 ion exchange Methods 0.000 description 2
• 229930027917 kanamycin Natural products 0.000 description 2
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
• 229960000318 kanamycin Drugs 0.000 description 2
• 229930182823 kanamycin A Natural products 0.000 description 2
• 239000003446 ligand Substances 0.000 description 2
• 239000006194 liquid suspension Substances 0.000 description 2
• 235000020905 low-protein-diet Nutrition 0.000 description 2
• 239000007937 lozenge Substances 0.000 description 2
• 235000019359 magnesium stearate Nutrition 0.000 description 2
• 239000000594 mannitol Substances 0.000 description 2
• 235000010355 mannitol Nutrition 0.000 description 2
• 238000013507 mapping Methods 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• 230000004060 metabolic process Effects 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• 229930182817 methionine Natural products 0.000 description 2
• 230000000813 microbial effect Effects 0.000 description 2
• 208000004141 microcephaly Diseases 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 238000010172 mouse model Methods 0.000 description 2
• 238000002887 multiple sequence alignment Methods 0.000 description 2
• 210000004898 n-terminal fragment Anatomy 0.000 description 2
• 239000013642 negative control Substances 0.000 description 2
• 230000001537 neural effect Effects 0.000 description 2
• 230000000926 neurological effect Effects 0.000 description 2
• 230000003557 neuropsychological effect Effects 0.000 description 2
• 239000002858 neurotransmitter agent Substances 0.000 description 2
• 235000021590 normal diet Nutrition 0.000 description 2
• 238000007899 nucleic acid hybridization Methods 0.000 description 2
• 239000002853 nucleic acid probe Substances 0.000 description 2
• 235000016709 nutrition Nutrition 0.000 description 2
• 235000014571 nuts Nutrition 0.000 description 2
• 229940035567 orencia Drugs 0.000 description 2
• 150000002923 oximes Chemical class 0.000 description 2
• 229910052760 oxygen Inorganic materials 0.000 description 2
• 239000001301 oxygen Substances 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 235000011197 perejil Nutrition 0.000 description 2
• 230000003285 pharmacodynamic effect Effects 0.000 description 2
• 230000000144 pharmacologic effect Effects 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• 239000008363 phosphate buffer Chemical class 0.000 description 2
• 230000026731 phosphorylation Effects 0.000 description 2
• 238000006366 phosphorylation reaction Methods 0.000 description 2
• 239000013612 plasmid Substances 0.000 description 2
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
• 229920000570 polyether Polymers 0.000 description 2
• 239000008057 potassium phosphate buffer Substances 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 229960002429 proline Drugs 0.000 description 2
• 230000000069 prophylactic effect Effects 0.000 description 2
• 230000001681 protective effect Effects 0.000 description 2
• 230000007026 protein scission Effects 0.000 description 2
• 230000017854 proteolysis Effects 0.000 description 2
• 230000002285 radioactive effect Effects 0.000 description 2
• 238000002708 random mutagenesis Methods 0.000 description 2
• 102000005962 receptors Human genes 0.000 description 2
• 108020003175 receptors Proteins 0.000 description 2
• 230000000717 retained effect Effects 0.000 description 2
• 235000009566 rice Nutrition 0.000 description 2
• 102220098936 rs763547482 Human genes 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• 150000003355 serines Chemical class 0.000 description 2
• 229940076279 serotonin Drugs 0.000 description 2
• 150000003384 small molecules Chemical class 0.000 description 2
• 239000001632 sodium acetate Substances 0.000 description 2
• 235000017281 sodium acetate Nutrition 0.000 description 2
• 239000001488 sodium phosphate Substances 0.000 description 2
• 229910000162 sodium phosphate Inorganic materials 0.000 description 2
• PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 239000007858 starting material Substances 0.000 description 2
• 230000001954 sterilising effect Effects 0.000 description 2
• 238000004659 sterilization and disinfection Methods 0.000 description 2
• 238000013268 sustained release Methods 0.000 description 2
• 239000012730 sustained-release form Substances 0.000 description 2
• 239000003765 sweetening agent Substances 0.000 description 2
• 208000011580 syndromic disease Diseases 0.000 description 2
• 239000003826 tablet Substances 0.000 description 2
• 239000013077 target material Substances 0.000 description 2
• 229960003080 taurine Drugs 0.000 description 2
• 229940124597 therapeutic agent Drugs 0.000 description 2
• 238000011285 therapeutic regimen Methods 0.000 description 2
• 125000003396 thiol group Chemical group [H]S* 0.000 description 2
• 229960002898 threonine Drugs 0.000 description 2
• 230000000699 topical effect Effects 0.000 description 2
• 231100000331 toxic Toxicity 0.000 description 2
• 230000002588 toxic effect Effects 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
• 229960004799 tryptophan Drugs 0.000 description 2
• 230000004614 tumor growth Effects 0.000 description 2
• DZGWFCGJZKJUFP-UHFFFAOYSA-N tyramine Chemical compound NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 2
• 241000556533 uncultured marine bacterium Species 0.000 description 2
• 238000011144 upstream manufacturing Methods 0.000 description 2
• 230000002485 urinary effect Effects 0.000 description 2
• 210000003462 vein Anatomy 0.000 description 2
• 238000009736 wetting Methods 0.000 description 2
• 238000002424 x-ray crystallography Methods 0.000 description 2
• 239000012138 yeast extract Substances 0.000 description 2
• CTBBEXWJRAPJIZ-VHPBLNRZSA-N (1S,2S,3S,6R,8R,9S,10R)-2-benzoyl-1,3,8,10-tetrahydroxy-9-(4-methoxy-6-oxopyran-2-yl)-5-oxatricyclo[4.3.1.03,8]decan-4-one Chemical compound O1C(=O)C=C(OC)C=C1[C@H]1[C@]([C@@H]2O)(O)[C@H](C(=O)C=3C=CC=CC=3)[C@@]3(O)C(=O)O[C@@H]2C[C@]31O CTBBEXWJRAPJIZ-VHPBLNRZSA-N 0.000 description 1
• LBXRPPWPQUZKBO-DKWTVANSSA-N (2s)-2-aminobutanedioic acid;hydrate Chemical compound O.OC(=O)[C@@H](N)CC(O)=O LBXRPPWPQUZKBO-DKWTVANSSA-N 0.000 description 1
• WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
• LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 1
• ICLYJLBTOGPLMC-KVVVOXFISA-N (z)-octadec-9-enoate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCC\C=C/CCCCCCCC(O)=O ICLYJLBTOGPLMC-KVVVOXFISA-N 0.000 description 1
• ICGQLNMKJVHCIR-UHFFFAOYSA-N 1,3,2-dioxazetidin-4-one Chemical compound O=C1ONO1 ICGQLNMKJVHCIR-UHFFFAOYSA-N 0.000 description 1
• WIIZWVCIJKGZOK-IUCAKERBSA-N 2,2-dichloro-n-[(1s,2s)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide Chemical compound ClC(Cl)C(=O)N[C@@H](CO)[C@@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-IUCAKERBSA-N 0.000 description 1
• UTIMBUCRNZURQB-UHFFFAOYSA-N 2-(propylamino)propanoic acid Chemical compound CCCNC(C)C(O)=O UTIMBUCRNZURQB-UHFFFAOYSA-N 0.000 description 1
• RDTRHBCZFDCUPW-KWICJJCGSA-N 2-[(4r,7s,10s,13s,19s,22s,25s,28s,31s,34r)-4-[[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]-34-[[(2s,3s)-2-amino-3-methylpentanoyl]amino]-25-(3-amino-3-oxopropyl)-7-[3-(diaminomethylideneamino)propyl]-10,13-bis(1h-imidazol-5-ylmethyl)-19-(1h-indol Chemical compound C([C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CSSC[C@@H](C(N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)NCC(=O)N[C@@H](CC=2NC=NC=2)C(=O)N1)C(C)C)C(C)C)=O)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=CN=CN1 RDTRHBCZFDCUPW-KWICJJCGSA-N 0.000 description 1
• QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 1
• 101710197207 2-iminoacetate synthase Proteins 0.000 description 1
• GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
• MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
• NZAQRZWBQUIBSF-UHFFFAOYSA-N 4-(4-sulfobutoxy)butane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCOCCCCS(O)(=O)=O NZAQRZWBQUIBSF-UHFFFAOYSA-N 0.000 description 1
• NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
• QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
• 108010054792 4-nitrobenzyl esterase Proteins 0.000 description 1
• FVEPUQVTLVLBMB-UHFFFAOYSA-N 5-methylidene-1h-imidazol-4-one Chemical compound C=C1N=CNC1=O FVEPUQVTLVLBMB-UHFFFAOYSA-N 0.000 description 1
• DMSIQWNKJSELSK-UHFFFAOYSA-N 5-methylimidazol-4-one Chemical compound CC1=NC=NC1=O DMSIQWNKJSELSK-UHFFFAOYSA-N 0.000 description 1
• XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
• ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
• DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
• 208000013824 Acidemia Diseases 0.000 description 1
• 208000010444 Acidosis Diseases 0.000 description 1
• 235000010686 Agastache rugosa Nutrition 0.000 description 1
• 240000004510 Agastache rugosa Species 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 208000029751 Amino acid metabolism disease Diseases 0.000 description 1
• 244000100578 Amorphophallus variabilis Species 0.000 description 1
• JTRCEEDCNBSKLP-UHFFFAOYSA-N Andrimid Natural products CC=CC=CC=CC(=O)NC(C(=O)NC(C(=O)C1C(C)C(=O)NC1=O)C(C)(C)C)c2ccccc2 JTRCEEDCNBSKLP-UHFFFAOYSA-N 0.000 description 1
• DJHGAFSJWGLOIV-UHFFFAOYSA-K Arsenate3- Chemical compound [O-][As]([O-])([O-])=O DJHGAFSJWGLOIV-UHFFFAOYSA-K 0.000 description 1
• 235000016425 Arthrospira platensis Nutrition 0.000 description 1
• 240000002900 Arthrospira platensis Species 0.000 description 1
• 244000063299 Bacillus subtilis Species 0.000 description 1
• 108010077805 Bacterial Proteins Proteins 0.000 description 1
• 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
• 244000289276 Bambusa oldhamii Species 0.000 description 1
• 235000017491 Bambusa tulda Nutrition 0.000 description 1
• 241001330002 Bambuseae Species 0.000 description 1
• 239000005711 Benzoic acid Substances 0.000 description 1
• 108020004256 Beta-lactamase Proteins 0.000 description 1
• 108030001720 Bontoxilysin Proteins 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 241000131481 Bromheadia finlaysoniana Species 0.000 description 1
• BUUJAVKEMFMGNB-UHFFFAOYSA-N C(CCC(=O)O)(=O)O.C(CCC)C1C(=O)NC(C1)=O Chemical compound C(CCC(=O)O)(=O)O.C(CCC)C1C(=O)NC(C1)=O BUUJAVKEMFMGNB-UHFFFAOYSA-N 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000253373 Caldanaerobacter subterraneus subsp. tengcongensis Species 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 241001300198 Caperonia palustris Species 0.000 description 1
• 102000003670 Carboxypeptidase B Human genes 0.000 description 1
• 108090000087 Carboxypeptidase B Proteins 0.000 description 1
• 102000000496 Carboxypeptidases A Human genes 0.000 description 1
• 108010080937 Carboxypeptidases A Proteins 0.000 description 1
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 241000700198 Cavia Species 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 241000207199 Citrus Species 0.000 description 1
• 241001673112 Citrus clementina Species 0.000 description 1
• 235000009088 Citrus pyriformis Nutrition 0.000 description 1
• 241000723377 Coffea Species 0.000 description 1
• 244000016593 Coffea robusta Species 0.000 description 1
• 208000032170 Congenital Abnormalities Diseases 0.000 description 1
• 229920002261 Corn starch Polymers 0.000 description 1
• 101710151559 Crystal protein Proteins 0.000 description 1
• 206010011732 Cyst Diseases 0.000 description 1
• 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
• 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
• 150000008574 D-amino acids Chemical group 0.000 description 1
• LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
• 101100285402 Danio rerio eng1a gene Proteins 0.000 description 1
• UQBOJOOOTLPNST-UHFFFAOYSA-N Dehydroalanine Chemical group NC(=C)C(O)=O UQBOJOOOTLPNST-UHFFFAOYSA-N 0.000 description 1
• 238000009007 Diagnostic Kit Methods 0.000 description 1
• 102100022317 Dihydropteridine reductase Human genes 0.000 description 1
• 102000016680 Dioxygenases Human genes 0.000 description 1
• 108010028143 Dioxygenases Proteins 0.000 description 1
• 102000004860 Dipeptidases Human genes 0.000 description 1
• 108090001081 Dipeptidases Proteins 0.000 description 1
• 241000588921 Enterobacteriaceae Species 0.000 description 1
• CTBBEXWJRAPJIZ-UHFFFAOYSA-N Enterocin Natural products O1C(=O)C=C(OC)C=C1C1C(C2O)(O)C(C(=O)C=3C=CC=CC=3)C3(O)C(=O)OC2CC31O CTBBEXWJRAPJIZ-UHFFFAOYSA-N 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 241001125671 Eretmochelys imbricata Species 0.000 description 1
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
• 239000005977 Ethylene Substances 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
• 102000002464 Galactosidases Human genes 0.000 description 1
• 108010093031 Galactosidases Proteins 0.000 description 1
• 102000034354 Gi proteins Human genes 0.000 description 1
• 108091006101 Gi proteins Proteins 0.000 description 1
• 102000006395 Globulins Human genes 0.000 description 1
• 108010044091 Globulins Proteins 0.000 description 1
• SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 238000002704 Guthrie test Methods 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 241000405147 Hermes Species 0.000 description 1
• 108091006054 His-tagged proteins Proteins 0.000 description 1
• 102000030789 Histidine Ammonia-Lyase Human genes 0.000 description 1
• 102100022695 Histidine ammonia-lyase Human genes 0.000 description 1
• 108700006308 Histidine ammonia-lyases Proteins 0.000 description 1
• 101100507848 Homo sapiens HAL gene Proteins 0.000 description 1
• 101001044626 Homo sapiens Histidine ammonia-lyase Proteins 0.000 description 1
• 101000959111 Homo sapiens Peptidyl-alpha-hydroxyglycine alpha-amidating lyase Proteins 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• 108090000144 Human Proteins Proteins 0.000 description 1
• 102000003839 Human Proteins Human genes 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• 102000004157 Hydrolases Human genes 0.000 description 1
• 108090000604 Hydrolases Proteins 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 206010020772 Hypertension Diseases 0.000 description 1
• 235000003332 Ilex aquifolium Nutrition 0.000 description 1
• 241000209027 Ilex aquifolium Species 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 206010021602 Inborn errors of amino acid metabolism Diseases 0.000 description 1
• 235000010702 Insulata Nutrition 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 240000001549 Ipomoea eriocarpa Species 0.000 description 1
• 235000005146 Ipomoea eriocarpa Nutrition 0.000 description 1
• 240000007218 Ipomoea hederacea Species 0.000 description 1
• 241001580017 Jana Species 0.000 description 1
• SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
• WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
• WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
• FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
• SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
• 229930064664 L-arginine Natural products 0.000 description 1
• 235000014852 L-arginine Nutrition 0.000 description 1
• 229930182844 L-isoleucine Natural products 0.000 description 1
• 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
• 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
• 239000004395 L-leucine Substances 0.000 description 1
• 235000019454 L-leucine Nutrition 0.000 description 1
• 229930195722 L-methionine Natural products 0.000 description 1
• SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
• 150000008547 L-phenylalanines Chemical class 0.000 description 1
• 229930182821 L-proline Natural products 0.000 description 1
• 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
• 241001071917 Lithospermum Species 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 208000002720 Malnutrition Diseases 0.000 description 1
• 235000004456 Manihot esculenta Nutrition 0.000 description 1
• 235000010624 Medicago sativa Nutrition 0.000 description 1
• 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
• 229920000877 Melamine resin Polymers 0.000 description 1
• UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
• 206010027480 Metastatic malignant melanoma Diseases 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
• SCIFESDRCALIIM-VIFPVBQESA-N N-methyl-L-phenylalanine Chemical compound C[NH2+][C@H](C([O-])=O)CC1=CC=CC=C1 SCIFESDRCALIIM-VIFPVBQESA-N 0.000 description 1
• 241000984654 Natrinema pallidum Species 0.000 description 1
• 241000187654 Nocardia Species 0.000 description 1
• 241000424623 Nostoc punctiforme Species 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000004316 Oxidoreductases Human genes 0.000 description 1
• 108090000854 Oxidoreductases Proteins 0.000 description 1
• 229920001734 PEG propionaldehyde Polymers 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 241000588912 Pantoea agglomerans Species 0.000 description 1
• 241000282520 Papio Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 244000062780 Petroselinum sativum Species 0.000 description 1
• 241001505935 Phalaenopsis Species 0.000 description 1
• 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
• 241000607568 Photobacterium Species 0.000 description 1
• 235000001550 Phyllostachys bambusoides Nutrition 0.000 description 1
• 240000007880 Phyllostachys bambusoides Species 0.000 description 1
• 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
• 235000017200 Phyllostachys vivax Nutrition 0.000 description 1
• 241000233614 Phytophthora Species 0.000 description 1
• 235000005105 Pinus pinaster Nutrition 0.000 description 1
• 241001236212 Pinus pinaster Species 0.000 description 1
• 235000016816 Pisum sativum subsp sativum Nutrition 0.000 description 1
• 239000004372 Polyvinyl alcohol Substances 0.000 description 1
• 241000219000 Populus Species 0.000 description 1
• 241000218978 Populus deltoides Species 0.000 description 1
• 241001479460 Populus sieboldii x Populus grandidentata Species 0.000 description 1
• 241000183024 Populus tremula Species 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
• 206010036790 Productive cough Diseases 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 1
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 1
• 241001290151 Prunus avium subsp. avium Species 0.000 description 1
• 208000003251 Pruritus Diseases 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 102000030764 Purine-nucleoside phosphorylase Human genes 0.000 description 1
• 206010037549 Purpura Diseases 0.000 description 1
• 241001672981 Purpura Species 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 241000405911 Rehmannia glutinosa Species 0.000 description 1
• 241000191023 Rhodobacter capsulatus Species 0.000 description 1
• 241000191043 Rhodobacter sphaeroides Species 0.000 description 1
• 241000433127 Rhodobacter sphaeroides 2.4.1 Species 0.000 description 1
• 241000187561 Rhodococcus erythropolis Species 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 241000096640 Rubrobacter xylanophilus DSM 9941 Species 0.000 description 1
• WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
• BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
• 229920002684 Sepharose Polymers 0.000 description 1
• 241001532577 Sorangium Species 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 241000187432 Streptomyces coelicolor Species 0.000 description 1
• 241000187436 Streptomyces globisporus Species 0.000 description 1
• 241000201081 Streptomyces maritimus Species 0.000 description 1
• 108090000787 Subtilisin Proteins 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 206010042434 Sudden death Diseases 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 235000005865 Symphytum officinale Nutrition 0.000 description 1
• 240000002299 Symphytum officinale Species 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• 235000006468 Thea sinensis Nutrition 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
• SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 101710120037 Toxin CcdB Proteins 0.000 description 1
• 206010044565 Tremor Diseases 0.000 description 1
• 101100406858 Trichormus variabilis (strain ATCC 29413 / PCC 7937) Ava_3988 gene Proteins 0.000 description 1
• 241000219793 Trifolium Species 0.000 description 1
• 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
• 108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
• LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
• 235000015919 Ustilago maydis Nutrition 0.000 description 1
• 244000301083 Ustilago maydis Species 0.000 description 1
• 235000000384 Veronica chamaedrys Nutrition 0.000 description 1
• 241000863480 Vinca Species 0.000 description 1
• 101710088929 Voltage-dependent L-type calcium channel subunit alpha-1S Proteins 0.000 description 1
• 235000007244 Zea mays Nutrition 0.000 description 1
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
• 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• 150000001242 acetic acid derivatives Chemical class 0.000 description 1
• RRNJROHIFSLGRA-JEDNCBNOSA-N acetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.NCCCC[C@H](N)C(O)=O RRNJROHIFSLGRA-JEDNCBNOSA-N 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
• 108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
• VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 208000022877 amino acid metabolic disease Diseases 0.000 description 1
• 229960002749 aminolevulinic acid Drugs 0.000 description 1
• 238000012435 analytical chromatography Methods 0.000 description 1
• OHDXGZAYYBMHCY-QSUIEZAASA-N andrimid Chemical compound O=C([C@H](C(C)C)NC(=O)C[C@H](NC(=O)/C=C/C=C/C=C/C)C=1C=CC=CC=1)[C@H]1[C@H](C)C(=O)NC1=O OHDXGZAYYBMHCY-QSUIEZAASA-N 0.000 description 1
• 238000005571 anion exchange chromatography Methods 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 230000005875 antibody response Effects 0.000 description 1
• 210000000612 antigen-presenting cell Anatomy 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
• 238000005899 aromatization reaction Methods 0.000 description 1
• 229940000489 arsenate Drugs 0.000 description 1
• 229920001718 aryloxy-PEG Polymers 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 239000000022 bacteriostatic agent Substances 0.000 description 1
• 230000003385 bacteriostatic effect Effects 0.000 description 1
• 239000011425 bamboo Substances 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
• 235000019445 benzyl alcohol Nutrition 0.000 description 1
• 238000002306 biochemical method Methods 0.000 description 1
• 238000005842 biochemical reaction Methods 0.000 description 1
• 238000007622 bioinformatic analysis Methods 0.000 description 1
• 239000006177 biological buffer Substances 0.000 description 1
• 230000031018 biological processes and functions Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 229920001222 biopolymer Polymers 0.000 description 1
• 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
• 235000010290 biphenyl Nutrition 0.000 description 1
• 239000004305 biphenyl Substances 0.000 description 1
• 230000007698 birth defect Effects 0.000 description 1
• OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
• 239000012496 blank sample Substances 0.000 description 1
• 238000006664 bond formation reaction Methods 0.000 description 1
• 229910000085 borane Inorganic materials 0.000 description 1
• 231100001103 botulinum neurotoxin Toxicity 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 230000004641 brain development Effects 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 230000003139 buffering effect Effects 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 159000000007 calcium salts Chemical class 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 208000029499 cancer-related condition Diseases 0.000 description 1
• 229960004205 carbidopa Drugs 0.000 description 1
• TZFNLOMSOLWIDK-JTQLQIEISA-N carbidopa (anhydrous) Chemical compound NN[C@@](C(O)=O)(C)CC1=CC=C(O)C(O)=C1 TZFNLOMSOLWIDK-JTQLQIEISA-N 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 230000021523 carboxylation Effects 0.000 description 1
• 238000006473 carboxylation reaction Methods 0.000 description 1
• 150000001735 carboxylic acids Chemical class 0.000 description 1
• 230000006652 catabolic pathway Effects 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 235000013339 cereals Nutrition 0.000 description 1
• 239000013522 chelant Substances 0.000 description 1
• 238000001311 chemical methods and process Methods 0.000 description 1
• 235000019693 cherries Nutrition 0.000 description 1
• 229960005091 chloramphenicol Drugs 0.000 description 1
• WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
• 235000019219 chocolate Nutrition 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 210000003703 cisterna magna Anatomy 0.000 description 1
• 235000020971 citrus fruits Nutrition 0.000 description 1
• 238000005352 clarification Methods 0.000 description 1
• RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
• 239000005515 coenzyme Substances 0.000 description 1
• 230000008133 cognitive development Effects 0.000 description 1
• 238000004040 coloring Methods 0.000 description 1
• 238000010835 comparative analysis Methods 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 108010027437 compstatin Proteins 0.000 description 1
• 238000005094 computer simulation Methods 0.000 description 1
• 230000002153 concerted effect Effects 0.000 description 1
• 235000013409 condiments Nutrition 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 238000011437 continuous method Methods 0.000 description 1
• 238000011340 continuous therapy Methods 0.000 description 1
• 239000003433 contraceptive agent Substances 0.000 description 1
• 230000002254 contraceptive effect Effects 0.000 description 1
• 239000012050 conventional carrier Substances 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 235000005822 corn Nutrition 0.000 description 1
• 239000008120 corn starch Substances 0.000 description 1
• 238000009223 counseling Methods 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 244000096108 cunha Species 0.000 description 1
• 208000031513 cyst Diseases 0.000 description 1
• UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical group NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
• 229960003067 cystine Drugs 0.000 description 1
• 235000013365 dairy product Nutrition 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 238000000354 decomposition reaction Methods 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
• 235000011850 desserts Nutrition 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 238000001784 detoxification Methods 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 235000021004 dietary regimen Nutrition 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 239000013024 dilution buffer Substances 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• 230000003292 diminished effect Effects 0.000 description 1
• 150000002009 diols Chemical class 0.000 description 1
• ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 235000021186 dishes Nutrition 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 229960003638 dopamine Drugs 0.000 description 1
• 238000007876 drug discovery Methods 0.000 description 1
• 230000036267 drug metabolism Effects 0.000 description 1
• 235000005489 dwarf bean Nutrition 0.000 description 1
• 235000013399 edible fruits Nutrition 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 230000001804 emulsifying effect Effects 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 238000002641 enzyme replacement therapy Methods 0.000 description 1
• 229960003276 erythromycin Drugs 0.000 description 1
• 235000020776 essential amino acid Nutrition 0.000 description 1
• 239000003797 essential amino acid Substances 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 238000000855 fermentation Methods 0.000 description 1
• 230000004151 fermentation Effects 0.000 description 1
• 230000035558 fertility Effects 0.000 description 1
• QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical class C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
• 239000011888 foil Substances 0.000 description 1
• 235000012631 food intake Nutrition 0.000 description 1
• 239000012537 formulation buffer Substances 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 239000013505 freshwater Substances 0.000 description 1
• 230000005714 functional activity Effects 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 229960002449 glycine Drugs 0.000 description 1
• 235000002532 grape seed extract Nutrition 0.000 description 1
• 239000005090 green fluorescent protein Substances 0.000 description 1
• 229960000789 guanidine hydrochloride Drugs 0.000 description 1
• PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 230000002440 hepatic effect Effects 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
• 239000008240 homogeneous mixture Substances 0.000 description 1
• 238000002744 homologous recombination Methods 0.000 description 1
• 230000006801 homologous recombination Effects 0.000 description 1
• 229920001519 homopolymer Polymers 0.000 description 1
• 239000003906 humectant Substances 0.000 description 1
• 229940014041 hyaluronate Drugs 0.000 description 1
• YPGCWEMNNLXISK-UHFFFAOYSA-N hydratropic acid Chemical class OC(=O)C(C)C1=CC=CC=C1 YPGCWEMNNLXISK-UHFFFAOYSA-N 0.000 description 1
• 150000003840 hydrochlorides Chemical class 0.000 description 1
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 238000000126 in silico method Methods 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 229940060367 inert ingredients Drugs 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 208000014468 inherited amino acid metabolic disease Diseases 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229940102213 injectable suspension Drugs 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000007914 intraventricular administration Methods 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 230000002427 irreversible effect Effects 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 230000029795 kidney development Effects 0.000 description 1
• 238000012933 kinetic analysis Methods 0.000 description 1
• 238000009533 lab test Methods 0.000 description 1
• 238000011005 laboratory method Methods 0.000 description 1
• 230000006651 lactation Effects 0.000 description 1
• 208000032839 leukemia Diseases 0.000 description 1
• 238000007834 ligase chain reaction Methods 0.000 description 1
• 229920005610 lignin Polymers 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
• 239000008297 liquid dosage form Substances 0.000 description 1
• 239000012669 liquid formulation Substances 0.000 description 1
• 239000006193 liquid solution Substances 0.000 description 1
• 230000003908 liver function Effects 0.000 description 1
• 239000012160 loading buffer Substances 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 238000009593 lumbar puncture Methods 0.000 description 1
• 208000003747 lymphoid leukemia Diseases 0.000 description 1
• 150000002669 lysines Chemical class 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
• 239000001095 magnesium carbonate Substances 0.000 description 1
• 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
• 159000000003 magnesium salts Chemical class 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 235000009973 maize Nutrition 0.000 description 1
• 201000010893 malignant breast melanoma Diseases 0.000 description 1
• 150000002690 malonic acid derivatives Chemical class 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 235000013372 meat Nutrition 0.000 description 1
• 235000013622 meat product Nutrition 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical group NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 229960003151 mercaptamine Drugs 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 208000021039 metastatic melanoma Diseases 0.000 description 1
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical class CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 231100000324 minimal toxicity Toxicity 0.000 description 1
• 238000002715 modification method Methods 0.000 description 1
• 238000003032 molecular docking Methods 0.000 description 1
• 229940057059 monascus purpureus Drugs 0.000 description 1
• 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
• 235000019796 monopotassium phosphate Nutrition 0.000 description 1
• CLVOYFRAZKMSPF-UHFFFAOYSA-N n,n-dibutyl-4-chlorobenzenesulfonamide Chemical compound CCCCN(CCCC)S(=O)(=O)C1=CC=C(Cl)C=C1 CLVOYFRAZKMSPF-UHFFFAOYSA-N 0.000 description 1
• SEEYREPSKCQBBF-UHFFFAOYSA-N n-methylmaleimide Chemical compound CN1C(=O)C=CC1=O SEEYREPSKCQBBF-UHFFFAOYSA-N 0.000 description 1
• 210000004897 n-terminal region Anatomy 0.000 description 1
• FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
• 239000012457 nonaqueous media Substances 0.000 description 1
• 239000000346 nonvolatile oil Substances 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 238000007833 oxidative deamination reaction Methods 0.000 description 1
• 239000006179 pH buffering agent Substances 0.000 description 1
• 235000012771 pancakes Nutrition 0.000 description 1
• 238000002161 passivation Methods 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 229960001639 penicillamine Drugs 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 238000012510 peptide mapping method Methods 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 239000012466 permeate Substances 0.000 description 1
• ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
• 150000004713 phosphodiesters Chemical class 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
• 239000011574 phosphorus Substances 0.000 description 1
• 230000000243 photosynthetic effect Effects 0.000 description 1
• 238000000053 physical method Methods 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 230000036470 plasma concentration Effects 0.000 description 1
• 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
• 229920001583 poly(oxyethylated polyols) Polymers 0.000 description 1
• 238000003752 polymerase chain reaction Methods 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 150000003077 polyols Chemical class 0.000 description 1
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
• 229920001451 polypropylene glycol Polymers 0.000 description 1
• 229950008882 polysorbate Drugs 0.000 description 1
• 229940068977 polysorbate 20 Drugs 0.000 description 1
• 229920000053 polysorbate 80 Polymers 0.000 description 1
• 229920002451 polyvinyl alcohol Polymers 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
• 229910000160 potassium phosphate Inorganic materials 0.000 description 1
• 235000011009 potassium phosphates Nutrition 0.000 description 1
• 230000003334 potential effect Effects 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 238000009597 pregnancy test Methods 0.000 description 1
• 238000004237 preparative chromatography Methods 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• 230000003449 preventive effect Effects 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• 230000004952 protein activity Effects 0.000 description 1
• 230000012846 protein folding Effects 0.000 description 1
• 230000009145 protein modification Effects 0.000 description 1
• 238000009163 protein therapy Methods 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 239000013014 purified material Substances 0.000 description 1
• 238000003259 recombinant expression Methods 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 238000007634 remodeling Methods 0.000 description 1
• 230000001846 repelling effect Effects 0.000 description 1
• 238000009256 replacement therapy Methods 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 238000004007 reversed phase HPLC Methods 0.000 description 1
• 229920002477 rna polymer Polymers 0.000 description 1
• 102220272831 rs55851803 Human genes 0.000 description 1
• 238000009938 salting Methods 0.000 description 1
• 210000001991 scapula Anatomy 0.000 description 1
• 235000014102 seafood Nutrition 0.000 description 1
• 229910052711 selenium Inorganic materials 0.000 description 1
• 239000011669 selenium Substances 0.000 description 1
• 239000008299 semisolid dosage form Substances 0.000 description 1
• 230000001953 sensory effect Effects 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 238000010008 shearing Methods 0.000 description 1
• 238000004904 shortening Methods 0.000 description 1
• 238000004088 simulation Methods 0.000 description 1
• IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
• 229960004249 sodium acetate Drugs 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
• 229940001584 sodium metabisulfite Drugs 0.000 description 1
• 235000010262 sodium metabisulphite Nutrition 0.000 description 1
• 159000000000 sodium salts Chemical class 0.000 description 1
• DCQXTYAFFMSNNH-UHFFFAOYSA-M sodium;2-[bis(2-hydroxyethyl)amino]ethanol;acetate Chemical compound [Na+].CC([O-])=O.OCCN(CCO)CCO DCQXTYAFFMSNNH-UHFFFAOYSA-M 0.000 description 1
• 239000007909 solid dosage form Substances 0.000 description 1
• 239000008247 solid mixture Substances 0.000 description 1
• 229940035044 sorbitan monolaurate Drugs 0.000 description 1
• 235000014347 soups Nutrition 0.000 description 1
• 235000013555 soy sauce Nutrition 0.000 description 1
• 229940063675 spermine Drugs 0.000 description 1
• 238000009987 spinning Methods 0.000 description 1
• 229940082787 spirulina Drugs 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 210000003802 sputum Anatomy 0.000 description 1
• 208000024794 sputum Diseases 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 235000000891 standard diet Nutrition 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 238000012916 structural analysis Methods 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
• 230000009469 supplementation Effects 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 230000009897 systematic effect Effects 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 239000013076 target substance Substances 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 238000010257 thawing Methods 0.000 description 1
• 229940124598 therapeutic candidate Drugs 0.000 description 1
• 231100001274 therapeutic index Toxicity 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
• 238000004809 thin layer chromatography Methods 0.000 description 1
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
• LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• 229940117013 triethanolamine oleate Drugs 0.000 description 1
• UORVGPXVDQYIDP-UHFFFAOYSA-N trihydridoboron Substances B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 1
• 239000012137 tryptone Substances 0.000 description 1
• 229960003732 tyramine Drugs 0.000 description 1
• 201000011296 tyrosinemia Diseases 0.000 description 1
• 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 235000000112 undernutrition Nutrition 0.000 description 1
• 238000002562 urinalysis Methods 0.000 description 1
• 210000002700 urine Anatomy 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 235000013311 vegetables Nutrition 0.000 description 1
• 238000012795 verification Methods 0.000 description 1
• 239000010455 vermiculite Substances 0.000 description 1
• 229910052902 vermiculite Inorganic materials 0.000 description 1
• 235000019354 vermiculite Nutrition 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 235000019155 vitamin A Nutrition 0.000 description 1
• 239000011719 vitamin A Substances 0.000 description 1
• 235000019166 vitamin D Nutrition 0.000 description 1
• 239000011710 vitamin D Substances 0.000 description 1
• 235000019165 vitamin E Nutrition 0.000 description 1
• 239000011709 vitamin E Substances 0.000 description 1
• 238000003260 vortexing Methods 0.000 description 1
• 239000002023 wood Substances 0.000 description 1
• 241001355366 x Doritaenopsis hybrid cultivar Species 0.000 description 1